Case Report

Published on 03 Sep 2024

Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms

in Cancer Immunity and Immunotherapy

Liying Yang
Mengdi Wu
Hao Yang
Xiaorong Sun
Lijie Xing
Dan Liu
Ligang Xing
Jinming Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1441404

1,239 views
1 citation

Review

Published on 02 Sep 2024

Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges

in Cancer Immunity and Immunotherapy

Lin Gan
Wei Wang
Jinxiu Jiang
Ke Tian
Wei Liu
Zhumin Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429836

1,357 views
1 citation

Original Research

Published on 02 Sep 2024

Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment

in Cancer Immunity and Immunotherapy

Yi Liu
Runyu Yang
Mengyao Zhang
Bingyu Yang
Yue Du
Hui Feng
Wenjuan Wang
Busheng Xue
Fan Niu
Pengcheng He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1402951

1,843 views

Original Research

Published on 02 Sep 2024

Prognostic cellular senescence-related lncRNAs patterns to predict clinical outcome and immune response in colon cancer

in Cancer Immunity and Immunotherapy

Lichao Cao
Fang Chen
Long Xu
Jian Zeng
Yun Wang
Shenrui Zhang
Ying Ba
Hezi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450135

1,127 views

Original Research

Published on 02 Sep 2024

Exploiting branched-chain amino acid metabolism and NOTCH3 expression to predict and target colorectal cancer progression

in Cancer Immunity and Immunotherapy

Kuan Shen
Chuming Zhu
Jianjun Wu
Jiang Yan
Pengyu Li
Shuqing Cao
Xinyi Zhou
Guozhong Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430352

1,009 views

Review

Published on 30 Aug 2024

γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations

in Cancer Immunity and Immunotherapy

Jeremy Wee Kiat Ng
Alice Man Sze Cheung

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438962

904 views

Review

Published on 30 Aug 2024

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy

in Cancer Immunity and Immunotherapy

Minggang Fang
Alexander Allen
Chong Luo
Jonathan D. Finn

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457629

2,505 views

Review

Published on 30 Aug 2024

Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles

in Cancer Immunity and Immunotherapy

Zhidu Song
Ying Tao
Yue Liu
Jian Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444437

1,465 views
1 citation

Review

Published on 30 Aug 2024

Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy

in Cancer Immunity and Immunotherapy

Shaoyan Shi
Xuehai Ou
Chao Liu
Hao Wen
Ke Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464267

939 views

Original Research

Published on 30 Aug 2024

Unveiling the cellular landscape: insights from single-cell RNA sequencing in multiple myeloma

in Cancer Immunity and Immunotherapy

Xinhan Li
Zhiheng Lin
Fu Zhao
Tianjiao Huang
Weisen Fan
Lijun Cen
Jun Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1458638

1,261 views

Systematic Review

Published on 30 Aug 2024

Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis

in Cancer Immunity and Immunotherapy

Yue Chen
Luyao Jia
Yu Li
Wenhao Cui
Jukun Wang
Chao Zhang
Chunjing Bian
Tao Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466113

1,223 views

Systematic Review

Published on 29 Aug 2024

Metabolic tumor volume and the survival of patients with Non-Hodgkin lymphoma treated with chimeric antigen receptor T cell therapy: a meta-analysis

in Cancer Immunity and Immunotherapy

Lin Liu
Feng Jin
Hua Fan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433012

1,011 views

Original Research

Published on 29 Aug 2024

Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Kun Ru
Liang Cui
Cong Wu
Xin X. Tan
Wen T. An
Qiang Wu
Yu T. Ma
Yu Hao
Xiao Xiao
Jing Bai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1347770

1,416 views

Review

Published on 29 Aug 2024

Decoding the secret of extracellular vesicles in the immune tumor microenvironment of the glioblastoma: on the border of kingdoms

in Cancer Immunity and Immunotherapy

Bouchra Ghazi
Zakia Harmak
Mounir Rghioui
Abdou-Samad Kone
Adil El Ghanmi
Abdallah Badou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423232

1,416 views

Review

Published on 29 Aug 2024

Unravelling oncosis: morphological and molecular insights into a unique cell death pathway

in Cancer Immunity and Immunotherapy

Jie Guo
Wen-tao Yang
Feng-yi Mai
Jing-rong Liang
Jiao Luo
Ming-chao Zhou
Dong-dong Yu
Yu-long Wang
Chen-guang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450998

1,362 views

Systematic Review

Published on 29 Aug 2024

Evaluating the efficacy and safety of different neoadjuvant immunotherapy combinations in locally advanced HNSCC: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Chang Liu
Mingzhu Li
Xiaojie Liu
Ting Shi
Yun Wang
Chaoyang Sui
Wenan Zhang
Bowen Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467306

1,331 views

Navigation group

Articles

Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms

Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges

Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment

Prognostic cellular senescence-related lncRNAs patterns to predict clinical outcome and immune response in colon cancer

Exploiting branched-chain amino acid metabolism and NOTCH3 expression to predict and target colorectal cancer progression

γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy

Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles

Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy

Unveiling the cellular landscape: insights from single-cell RNA sequencing in multiple myeloma

Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis

Metabolic tumor volume and the survival of patients with Non-Hodgkin lymphoma treated with chimeric antigen receptor T cell therapy: a meta-analysis

Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma

Decoding the secret of extracellular vesicles in the immune tumor microenvironment of the glioblastoma: on the border of kingdoms

Unravelling oncosis: morphological and molecular insights into a unique cell death pathway

Evaluating the efficacy and safety of different neoadjuvant immunotherapy combinations in locally advanced HNSCC: a systematic review and meta-analysis